Discovery, design, and analysis of novel allergen peptide therapeutics (Trial Not Registered)

Aravax - cashew/walnut/hazelnut

This trial is Currently recruiting
Registration number Trial Not Registered
Blood samples from people with nut allergies – cashew, walnut and hazelnut. This is to research how a peptide immunotherapy can be developed for people with specific nut allergies. This is to overall support the discovery, design and future testing of peptide therapies.

Program & service

This trial is being run with the Heart & Lung service, and as part of the Respiratory program.

Trial phase

Other

Trial participation type

This trial is for clinical research of something other than a drug or device.

Principal investigator

Prof Mark Hew

Key inclusion data

Inclusion: Confirmed history of nut allergy with positive SPT and/or RAST, Not able to eat the specific nut in question, Aged between 18-65yrs, Able to donate 100mls. Exclusion: Current biologic therapy.

If you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.